Limited Use Note(s)

Government of Ontario Logo
FLUDARABINE PHOSPHATE10mg Tab
Reason For Use CodeClinical Criteria
424For the first-line treatment of chronic lymphocytic leukemia (CLL) in combination with rituximab (with or without cyclophosphamide).
LU Authorization Period: Indefinite
379For second line therapy of patients with chronic lymphocytic leukemia (CLL) who have failed or are intolerant to chlorambucil.
LU Authorization Period: Indefinite